Prevalence of HBV Sero-markers in two Di f ferent Socioeconomic Groups of Schoolchildren from Abidjan, Côte d’ Ivoire
Abstract
Keywords
References
World Health Organization – Hepatitis B vaccines. Weekly
Epidemiological Record 2009; 40: 405-420
Lavanchy D. Hepatitis B virus epidemiology, disease
burden, treatment, and current and emerging prevention
and control measure. J Viral Hepat 2004; 11: 97-107
Lohouès-Kouacou MJ, Touré M, Hillah J, Camara BM, N'Dri
N, Kouamé KJ, Attia Y. Materno-foetal transmission of
hepatitis B virus in Ivory Coast. Plea for mass vaccination.
Sante 1998; 8: 401-104
Bile K, Mohamud O, Aden C, Isse A, Norder H, Nilsson
L, Magnius L. The risk for hepatitis A, B, and C at
two institutions for children in Somalia with different
socioeconomic conditions. Am J Trop Med Hyg 1992; 47:
-364
Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SFA, Jafar T,
Akhtar S, Hamid S, Shah HA, Nizami SQ. Hepatitis B and
C: prevalence and risk factors associated with seropositivity
among children in Karachi, Pakistan. BMC Infectious Diseases
, 6: 101-111
Gandolfo GM, Ferri GM, Conti L, Antenucci A, Marrone R,
Frasca AM, Vitelli G. Prevalence of infections by hepatitis A,
B, C and E viruses in two different socioeconomic groups of
children from Santa Cruz, Bolivia. Med Clin (Barc) 2003; 24;
: 725-727
Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M,
Lantum D, Kaptue L, Chionne P, Conti S, Sarrecchia B,
Naccarato R. Hepatitis B virus infection in Cameroon: a
seroepidemiological survey in city school children. J Med
Virol 1991; 33: 95-99
D a v a a l k h a m D , O j i m a T , N y m a d a w a P , T s e n d N ,
Lkhagvasuren T, Wiersma S, Uehara R, Watanabe M,
Oki I, Nakamura Y. Seroepidemiology of hepatitis B
virus infection among children in Mongolia: results of a
nationwide survey. Pediatr Int 2007; 49: 368-374
M a g o n i M , E k r a K D , A k a L N , S i t a K S , K a n g a K .
Effectiveness of hepatitis-B vaccination in Ivory Coast: the
case of the Grand Bassam health district. Ann Trop Med
Parasito 2009; 103: 519-527
Migliani R, Rousset D, Rakoto-Andrianarivelo M,
Rabarijaona L, Ratsitorahina M, Rajaonarivony V, Mauclère
P. Hepatitis B virus infection: a public health problem in
Madagascar. Arch Inst Pasteur Madagascar 2000; 66: 50-54
Rui WZ, Lo Baïdy B, N'Diaye M.. Hepatitis B virus infection
in the school milieu of Kiffa and Selibaby, Mauritania. Bull
Soc Pathol Exot 1998; 91: 247-248
Alikor EA, Erhabor ON. Seroprevalence of hepatitis
B surface antigenaemia in children in a tertiary health
institution in the Niger Delta of Nigeria. Niger J Med 2007;
: 250-251
Martinson FE, Weigle KA, Mushahwar IK, Weber DJ, Royce
R, Lemon SM. Seroepidemiological survey of hepatitis B
and C virus infections in Ghanaian children. J Med Virol
; 48: 278-283
Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T,
Cutts FT. Seroepidemiology of hepatitis B virus in Addis
Ababa, Ethiopia: transmission patterns and vaccine control.
Epidemiol Infect 2003; 131: 757-770
Assi C, Ouattara A, Allah Kouadio E, Diakite M, Koné S,
Lohoues Kouacou MJ, Camara BM. Vaccination coverage
against hepatitis B and prevalence of HBsAg: a crosssectional
study involving 592 persons attending public
screening in Abidjan. Clin Res Hepatol Gastroenterol 2011; 35:
-507
Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe
P, Leroy V, Dabis F, Rouzioux C; ANRS 1236 DITRAMEB&
C Study Group. HBV and HCV prevalence and viraemia
in HIV-positive and HIV-negative pregnant women in
Abidjan, Côte d'Ivoire: the ANRS 1236 study. J Med Virol
; 74: 34-40
Reda AA, Arafa MA, Youssry AA, Wandan EH, Ab de Ati
M, Daebees H. Epidemiologic evaluation of the immunity
against hepatitis B in Alexandria, Egypt. Eur J Epidemiol
; 18: 1007-1011
Ang LW, Tey SH, Cutter J, James L, Goh KT. Seroprevalence
of hepatitis B virus infection among children and
adolescents in Singapore, 2008-2010. J Med Virol 2013; 85:
-588
Vandermeulen C, Roelants M, Theeten H, Depoorter AM,
Van Damme P, Hoppenbrouwers K. Vaccination coverage
in 14-year-old adolescents: documentation, timeliness,
and sociodemographic determinants. Pediatrics 2008; 121:
e428-34.
Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos
T, Petridou ET. Seroprevalence and risk factors for hepatitis
A, B, and C among Roma and non-Roma children in a
deprived area of Athens, Greece. J Med Virol 2008; 80:
-797
Dowd JB, Zajacova A, Aiello A. Early origins of health
disparities: burden of infection, health, and socioeconomic
status in U.S. children. Soc Sci Med 2009; 68: 699–707
Ategbo S, Ngoungou EB, Koko J, Vierin Y, Zang Ndong
CE, Moussavou Mouyama A. Immunization coverage of
children aged 0 to 5 years in Libreville (Gabon). Sante 2010;
: 215-219
Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang
DC, Ni YH, Chen CJ, Chen DS; Taiwan Childhood HCC
Study Group. Prevention of hepatocellular carcinoma by
universal vaccination against hepatitis B virus: the effect
and problems. Clin Cancer Res 2005; 11: 7953-7957
Ni YH, Chen DS. Hepatitis B vaccination in children: the
Taiwan experience. Pathol Biol (Paris) 2010; 58: 296-300
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.